Showing Page 4 of 7
Posted: 04/13/2022
Blue Cross Complete Current Formulary Changes / Health Plan News
Blue Cross Complete (BCC) Current Formulary changes take effect May 1, 2022.
Posted: 04/08/2022
Medicaid Covers New Weight Loss Medications / OSP News
Medicaid updated their drug formulary for weight loss medications.
Posted: 04/04/2022
Molina Communication for April 2022 / Health Plan News
This article is a comprehensive communication of Molina operational updates as of April 2022.
Posted: 04/01/2022
National Imaging Associates (NIA) Medical Specialty Solutions Program Provider Webinars / Health Plan News
Blue Cross Complete has entered into an agreement with National Imaging Associates, Inc., a subsidiary of Magellan Health, to provide management and prior authorization of diagnostic imaging services such as MRI/CT/PET scans.
Posted: 04/01/2022
Blue Cross Complete (BCC) of Michigan April 2022 Complete Update / Health Plan News
Blue Cross Complete (BCC) of Michigan April 2022 Complete Update.
Posted: 03/31/2022
FDA Approves Higher Dose of Ozempic / OSP News
Ozempic is now available in three doses to improve blood sugar in people with type 2 diabetes.
Posted: 03/30/2022
Thank You OSP Doctors! / OSP News
Happy Doctors' Day! OSP Doctors always go above and beyond, working tirelessly towards health outcomes.
Posted: 03/28/2022
Michigan Collaborative for Type 2 Diabetes Cohort 2 Enrollment Opportunity / OSP News
The Michigan Collaborative for Type 2 Diabetes (MCT2D) is the first collaborative quality initiative (CQI) to be implemented at the primary care level. The mission of this CQI is to prevent and reverse the progression of type 2 diabetes using three key initiatives.
Posted: 03/22/2022
Blue Cross Complete to Implement New “Connecting Our Members to Premier Ancillary Services and Specialists” COMPASS Program / Health Plan News
Blue Cross Complete will implement the AmeriHealth Caritas COMPASS, a referral optimization initiative designed to give referring primary care providers information about specialists’ performance as measured by established and objective quality and efficiency performance measures.
Posted: 03/15/2022
Blue Cross Complete Updates Authorization Requirements / Health Plan News
Blue Cross Complete (BCC) recently updated authorization requirements.
Posted: 03/11/2022
Providers Need to Re-attest With CAQH Every 120 Days / OSP News
Oakland Southfield Physicians wants to remind you that you’re required to re-attest through CAQH every 120 days.
Posted: 03/10/2022
Priority Health Wants to Make Sure You Know to Re-attest With CAQH Every 120 Days / Health Plan News
Priority Health want to tell you not to forget that you’re required to re-attest through CAQH every 120 days.
Posted: 03/04/2022
Blue Cross Complete Will Be Using National Imaging Associates to Manage Diagnostic Imaging Services for Blue Cross Complete / Health Plan News
Blue Cross Complete has entered into an agreement with National Imaging Associates Inc., a subsidiary of Magellan Health, to manage diagnostic imaging services such as MRI/CT/PET scans.
Posted: 03/04/2022
Blue Cross Complete (BCC) of Michigan March/April 2022 Newsletter / Health Plan News
Blue Cross Complete (BCC) of Michigan March/April 2022 Newsletter.
Posted: 03/04/2022
Blue Cross Complete Newborn Prior Authorization Requests / Health Plan News
Blue Cross Complete (BCC) is currently experiencing an internal processing issue for neonatal newborn prior authorization requests, causing claims to deny in error.
Posted: 03/04/2022
Molina Communication for March 2022 / Health Plan News
This article is a comprehensive communication of Molina operational updates as of March 2022.
Posted: 03/02/2022
Priority Health Allows The Use POS 10 For Virtual Services Provided In The Patient’s Home / Health Plan News
As of January 1, 2022, Priority Health now accepts two place of service (POS) codes for virtual services.
Posted: 03/02/2022
Priority Health’s Clinical Pharmacists Are Calling Members About Medication Adherence / Health Plan News
Priority Health’s clinical pharmacists are reaching out to some of their members to improve their medication adherence.
Posted: 03/01/2022
FDA Approves Empagliflozin (Jardiance) for Heart Failure Regardless of Ejection Fraction / OSP News
This means the SGLT2 inhibitor, once considered primarily an antidiabetic agent, is approved for use in patients with heart failure per se without regard to ventricular function. The drug received approval for heart failure with reduced left-ventricular ejection fraction (LVEF) in August of 2021.
Posted: 03/01/2022
Blue Cross Complete Referring Provider Claims – Update / Health Plan News
Blue Cross Complete (BCC) claims submission and processing guidance for referring provider updates.
Search OSP